After years of industry-wide disinvestment from antibiotic research, a few large companies are re-investing.The lowdown: In 1999, Roche was one of the first large pharmaceutical companies to pull out of antibiotic research. Bristol-Myers Squibb, Lilly, Abbott, Bayer and others followed, and Pfizer closed Bron: Nature Reviews Drug Discovery | lees verder..
↧